Effect of Testosterone on Insulin Stimulated IRS1 Ser Phosphorylation in Primary Rat Myotubes—A Potential Model for PCOS-Related Insulin Resistance by Allemand, Michael C. et al.
Effect of Testosterone on Insulin Stimulated IRS1 Ser
Phosphorylation in Primary Rat Myotubes—A Potential
Model for PCOS-Related Insulin Resistance
Michael C. Allemand
1, Brian A. Irving
2, Yan W. Asmann




1, K. Sreekumaran Nair
2*
1Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Mayo Clinic Graduate School of Medicine, Rochester, Minnesota, United
States of America, 2Department of Internal Medicine, Endocrine Research Unit, Mayo Clinic Graduate School of Medicine, Rochester, Minnesota, United States of America
Abstract
Background: Polycystic ovary syndrome (PCOS) is characterized by a hyperandrogenic state and frequently develops
skeletal muscle insulin resistance. We determined whether testosterone adversely affects insulin action by increasing serine
phosphorylation of IRS-1
636/639 in differentiated rat skeletal muscle myotubes. The phosphorylation of Akt, mTOR, and S6K,
downstream targets of the PI3-kinase-IRS-1 complex were also studied.
Methods: Primary differentiated rat skeletal muscle myotubes were subjected to insulin for 30 min after 16-hour pre-exposure





389 were measured by Western blot with signal intensity measured by immunofluorescence.
Results: Cells exposed to 100 nM of insulin had increased IRS-1 Ser
636/639 and Akt Ser
473 phosphorylation. Cells pre-exposed
to low-dose testosterone had significantly increased insulin-induced mTOR-Ser
2448 and S6K-Thr
389 phosphorylation
(p,0.05), and further increased insulin-induced IRS-1 Ser
636/639 phosphorylation (p=0.042) compared to control cells. High-
dose testosterone pre-exposure attenuated the insulin-induced mTOR-Ser
2448 and S6K-Thr
389 phosphorylation.
Conclusions: The data demonstrated an interaction between testosterone and insulin on phosphorylation of intracellular
signaling proteins, and suggests a link between a hyperandrogenic, hyperinsulinemic environment and the development of
insulin resistance involving serine phosphorylation of IRS-1 Ser
636/639. These results may guide further investigations of
potential mechanisms of PCOS-related insulin resistance.
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Introduction
Polycystic Ovary Syndrome (PCOS) is estimated to affect
approximately 5–7% of premenopausal women in the U.S., and is
associated with a significant risk of developing type 2 diabetes
(T2D) independent of obesity [1]. PCOS is characterized by a
hyperandrogenic state and exposure to exogenous testosterone (T)
in vivo has been associated with insulin resistance in rats and
human females [2–4]. However, the mechanism by which
hyperandrogenism results in the development of insulin resistance
remains incompletely defined. The risk of developing the
metabolic syndrome in adolescent females with PCOS correlates
strongly with increased bioavailable T concentrations, indepen-
dent of obesity [5]. In addition, a recent systematic review
demonstrated a significantly higher risk of developing T2D
mellitus in women with elevated T concentrations [6].
Insulin receptor substrate-1 (IRS-1) is a signaling protein which
couples the insulin receptor to the phosphoinositide-3-kinase (PI3K)
signaling cascade [7]. Serine phosphorylation of IRS-1 disassociates
coupling of IRS-1 signal transduction to PI3K and results in insulin
resistance. Exposure to a number of metabolites, including free fatty
acids, glucose, diacylglycerol, and fatty acyl-CoA’s increase serine
phosphorylation of IRS-1 and result in impaired insulin signaling
[8]. Skeletal muscle and liver cells from obese rats have been shown
todemonstrateelevatedIRS-1serinephosphorylationandimpaired
insulin signaling through the PI3K pathway [9]. In addition, IRS-1
associated PI3K activity has been shown to be decreased in vivo in
skeletal muscle of PCOS patients, and cultured skeletal muscle from
PCOS patients has been shown to have elevated levels of IRS-1
serine phosphorylation as compared to age and body mass index
(BMI) matched controls [10,11].
The purpose of the current study was to test the hypothesis that
T exposure increases serine phosphorylation of IRS-1 in skeletal
muscle, the dominant site of insulin mediated glucose uptake in the
postprandial state, in a hyperinsulinemic environment. Previous
studies have shown that increased phosphorylation of mTOR and
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4274S6K causes sub-cellular redistribution of IRS-1, and inactivates
IRS-1 by increasing its serine phosphorylation leading to insulin
resistance [9,12–15].
In an effort to further investigate aberrations in insulin signaling
under these experimental conditions, we also studied the
phosphorylation of Akt, mTOR, and S6K, which lie downstream
of the PI3-kinase-IRS-1 complex.
Results
Homogeneity of myoblast culture
Immunohistochemistry staining of primary cultured rat myo-
blast cells showed positive MHC-1 in .95% of the cells,
confirming the successful isolation and primary culture of skeletal
muscle cells (Figure 1).
The impact of T exposure on the phosphorylation of
insulin signaling proteins
IRS-1. Exposure of differentiated rat skeletal muscle myotubes
to 100 nM insulin significantly increased phosphorylation of IRS-1
Ser
636/639 at 120 Min (p=0.036,Figure 2A). Phosphorylation of
IRS-1 Ser
636/639 was also elevated at 30 and 60 Min (Figure 2A),
however, these elevations in IRS-1 Ser
636/639 phosphorylation did
not reach the level of statistical significance. Cells pre-exposed for
16 hours to low T concentrations (20 ng/mL) had a significantly
greater insulin-induced IRS-1 Ser
636/639 phosphorylation
compared to non-T exposed (control) cells (p=0.042, figure 2B)
following 30 minutes of exposure to 100 nM of insulin. Cells pre-
exposed for 16 hours to high T concentrations (200 ng/ml) resulted
in a non-significant increase inIRS-1Ser
636/639compared to non-T
exposed(control)cells (p=0.205,Figure2B)following30 minutes of
exposure to 100 nM of insulin. Exposure to neither low-dose T nor
high-dose T alone affected IRS-1 Ser
636/639 phosphorylation.
Akt. Exposure to 100 nM insulin resulted in increases in Akt
phosphorylation at all time points: 10, 20, 30, 60, and 120 minutes
(p=0.028, p=0.072, p=0.007, p=0.016, and p=0.011,
respectively, Figure 3A). Cells pre-exposed for 16 hours to both
low (20 ng/mL) and high (200 ng/mL) T concentrations resulted
in no significant changes in Akt phosphorylation compared to non-
T exposed (control) cells (Figure 3B) following 30 minutes of
exposure to 100 nM of insulin.
mTOR. Exposure to 100 nM insulin at 10, 20, 30, 60, and
120 minutes did not change mTOR phosphorylation at any time
point (figure 4A). Cells pre-exposed for 16 hours to low T
concentrations (20 ng/mL) had a 40% increase in insulin-induced
mTOR phosphorylation compared to non-T exposed (control)
cells (p=0.017, Figure 4B) following 30 minutes of exposure to
100 nM of insulin. Cells pre-exposed for 16 hours to high T
concentrations (200 ng/mL) resulted in a borderline-significant
reduction in mTOR phosphorylation compared to non-T exposed
(control) cells (p=0.088, Figure 4B) following 30 minutes of
exposure to 100 nM of insulin.
S6K. Exposure to 100 nM insulin resulted in a significant
increase in S6K phosphorylation at time point 60 minute
compared to that of baseline (p=0.025, Figure 5A). The cells
pre-exposed for 16 hours to low T concentrations (20 ng/mL) had
a 52% increase in insulin stimulated S6K phosphorylation
compared to non-T exposed (control) cells following 30 minutes
of exposure to 100 nM of insulin (p=0.020, Figure 5B). When
cells were pre-exposed to high T concentrations (200 ng/mL),
there were no significant changes in S6K phosphorylation
compared to that of non-T exposed (control) cells following
30 minutes of exposure to 100 nM of insulin (Figure 5B).
Discussion
The current study reports a link between a hyperinsulinemic/
hyperandrogenic environment and an elevation in serine phos-
phorylation of IRS-1, which has been associated with insulin
resistance. More specifically, these results suggest there is a
synergistic interaction between T and hyperinsulinemia in its effect
beyond that of hyperinsulinemia alone. At both the low and high
doses of T, IRS-1 demonstrated an ,300% increase in insulin
stimulated Ser
636/639 phosphorylation. Regarding the Akt-
mTOR-S6K pathway, low-dose testosterone exposure significantly
increased both mTOR and S6K phosphorylation by insulin
compared to those from control cells that were not pre-exposed to
testosterone. There are other factors causing insulin resistance,
known to be involved in elevated IRS-1 serine phosphorylation
including tumor necrosis factor a (TNF-a), free fatty acids, cellular
stress, amino acids, and insulin [16]. These molecules are thought
to act on IRS-1 through a variety of serine/threonine kinases
including mTOR and S6K [9,12,16,17]. Therefore, low-dose
testosterone seems to elevate insulin-induced IRS-1 serine
phosphorylation similar to TNF-a, free fatty acids, amino acids,
and insulin.
Of note, we did not observe any significant changes in insulin-
associated mTOR/S6K phosphorylation when cells were pre-
exposed to a higher dose of testosterone, which may be due to the
desensitization of mTOR/S6K to insulin under current in vitro
conditions. Other studies have suggested that mTOR’s effect on
IRS-1 Ser
636/639 phosphorylation is mediated through TNF-a
[17]. Our data demonstrating increased phosphorylation of
mTOR and S6K paralleling that of IRS-1 Ser
636/639 phosphor-
ylation in response to a hyperandrogenic, hyperinsulinemic
stimulus are consistent with these prior studies. Additionally, the
observed increase in mTOR and S6K insulin stimulated
phosphorylation following T exposure was not observed for Akt,
which is consistent with the findings of Khamzina et al [9], which
demonstrated elevated IRS-1 Ser
636/639 resulted in suppression of
Akt phosphorylation.
Figure 1. There was no contamination of non-myoblast cells in
our primary culture of rat skeletal muscle cells. Cells were
positively stained with MHCI-antibody (Green Florescence).
doi:10.1371/journal.pone.0004274.g001
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636/639 phosphorylation has previously been
reported in liver and skeletal muscles of obese, insulin-resistant rats
under insulin stimulation [9], which is similar to our observations
where insulin alone significantly stimulated IRS-1 Ser
636/639
phosphorylation at time point 120 minute (Figure 2A). The same
study also suggested that suppressed Akt activity in liver and
skeletal muscle of the obese animals is potentially due to the IRS-1
Ser
636/639 phosphorylation secondary to insulin resistance, which
Figure 2. The effect of insulin in IRS-1 phosphorylation with or without pre-exposure of low and high dose testosterone. (A). The
effect of insulin alone on IRS-1 phosphorylation after insulin treatment for 10, 20, 30, 60, and 120 minutes; Insulin significantly increased IRS-1
Ser
636/639 phosphorylation after 120 minutes; (B). Cells were pre-exposed to low-dose (20ng/ml) or high-dose (200ng/ml) of testosterone for 16 hours
before insulin treatment. Compared to non-testosterone treated (control) cells, IRS-1 Ser
636/639 phosphorylation was significantly increased with both
low and high-dose testosterone exposure. Representative western blots are shown above the bar graphs. The four experimental groups are: control
cells without insulin (C2I), control cells plus insulin (C+I), testosterone exposed cells without insulin (T2I), and testosterone exposed cells plus insulin
(T+I). The phosphorylated signal of IRS-1 Ser
636/639 is normalized to total IRS-1 in the sample.
doi:10.1371/journal.pone.0004274.g002
Figure 3. The effect of insulin in Akt Ser
473 phosphorylation with or without pre-exposure of low and high dose testosterone. (A).
The effect of insulin alone on Akt phosphorylation after insulin treatment for 10, 20, 30, 60, and 120 minutes; Insulin significantly increased Akt Ser
473
phosphorylation at all time points except 20 minutes; (B). Cells were pre-exposed to low-dose (20ng/ml) or high-dose (200ng/ml) of testosterone for
16 hours before insulin treatment. No change in Akt Ser
473 phosphorylation was observed between T treated and non-T treated cells. Representative
western blots are shown above the bar graphs. The four experimental groups are: control cells without insulin (C2I), control cells plus insulin (C+I),
testosterone exposed cells without insulin (T2I), and testosterone exposed cells plus insulin (T+I). The phosphorylated signal of Akt Ser
473 is
normalized to total Akt in the sample.
doi:10.1371/journal.pone.0004274.g003
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2448 phosphorylation with or without pre-exposure of low and high dose testosterone.
(A). The effect of insulin alone on mTOR Ser
2448 phosphorylation after insulin treatment for 10, 20, 30, 60, and 120 minutes; Insulin had no effect on
mTOR Ser
2448 phosphorylation at all time points; (B). Cells were pre-exposed to low-dose (20ng/ml) or high-dose (200ng/ml) of testosterone for
16 hours before insulin treatment. Compared to non-testosterone treated cells, mTOR Ser
2448 phosphorylation was significantly increased with low-
dose testosterone treatment. Representative western blots are shown above the bar graphs. The four experimental groups are: control cells without
insulin (C2I), control cells plus insulin (C+I), testosterone exposed cells without insulin (T2I), and testosterone exposed cells plus insulin (T+I). The
phosphorylated signal of mTOR Ser
2448 is normalized to total mTOR in the sample.
doi:10.1371/journal.pone.0004274.g004
Figure 5. The effect of insulin in S6K Thr
389 phosphorylation with or without pre-exposure of low and high dose testosterone. (A).
The effect of insulin alone on S6K Thr
389 phosphorylation after insulin treatment for 10, 20, 30, 60, and 120 minutes; Insulin significantly increased S6K
Thr
389 phosphorylation after 60 minutes; (B). Cells were pre-exposed to low-dose (20ng/ml) or high-dose (200ng/ml) of testosterone for 16 hours
before insulin treatment. Compared to non-testosterone treated cells, S6K Thr
389 phosphorylation was significantly increased with low-dose
testosterone treatment. Representative western blots are shown above the bar graphs. The four experimental groups are: control cells without insulin
(C2I), control cells plus insulin (C+I), testosterone exposed cells without insulin (T2I), and testosterone exposed cells plus insulin (T+I). The
phosphorylated signal of S6K Thr
389 is normalized to total S6K in the sample.
doi:10.1371/journal.pone.0004274.g005
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reduced insulin signaling through Akt [9].
The results from the current study offer an opportunity to better
understand the underlying mechanism of insulin resistance in
PCOS patients. The association between hyperandrogenism and
insulin resistance is well established in both animal models and
humans. Multiple mechanisms have been suggested based on
animal studies including reduced skeletal muscle capillary
formation, muscle fiber isoform switching, reduced glycogen
synthase activity, and impaired insulin-induced glucose transporter
4 (GLUT4) plasma membrane translocation [18–21]. However,
much of the data regarding hyperandrogenic insulin resistance in
humans has been observational [5,6,22,23].
Studies of the mechanism of insulin resistance of PCOS have
found evidence of altered serine phosphorylation in the insulin
receptors of cultured skin fibroblasts from PCOS patients, which
inhibited IR activationbytyrosineautophosphorylationinresponse
to insulin stimulation [24,25]. Of note, PCOS patients had
significant elevations in both total and bioavailable T compared
to the control subjects.A recent study using cultured skeletal muscle
from 10 PCOS patients and matched control subjects reported a
35% significant increase in IRS-1 protein abundance in cultured
skeletal muscle of PCOS patients, and the insulin stimulated IRS-1
associated PI3K activity was reduced in the PCOS patients [11]. In
addition, insulin stimulated IRS-1 Ser
312 was 55% higher in the
PCOS patients as compared to controls, even after controlling for
the elevation in IRS-1 protein abundance in these subjects [11].
The present study took the next logical step by examining the
effects of both low-dose and high-dose testosterone exposure on
insulin-induced phosphorylation of serine (inhibitory) residues on
IRS-1 as well as some of its downstream targets. This finding from
the current study is consistent with that of Courbold et al and
demonstrates that increased insulin stimulated IRS-1 Ser phos-
phorylation occurs in cultured rat skeletal muscle after pre-
exposure to T. Although there are at least 50 known potential
serine/threonine phosphorylation sites on IRS-1, most studies
relating IRS-1 serine phosphorylation to insulin resistance study
one, or at most several, sites in response to a given stimulus
[9,11,14,16,17,26,27]. Elevations in phosphorylation at both IRS-1
sites, Ser
312 and Ser
636/639, have been reported in other studies in
association with insulin resistance [9,17,27].
The fact that we observed a similar trend to increase insulin-
induced IRS-1 serine phosphorylation with both doses of T
indicates that both the low- and high-dose T exposure enhanced
insulin-induced IRS-1 serine phosphorylation. It should be noted
that the low-dose T concentrations is at the upper limit of the
physiological range, which demonstrated a significant IRS-1 serine
phosphorylation and although the larger dose of T showed similar
trend it did not reach the level of statistical significance. There
may be multiple pathways and signaling proteins other than IRS-1
involved in this interaction between T and insulin. Previous studies
suggested other pathways such as the mitogen activated protein
kinase (MAPK) pathway and the stress activated protein kinase
JNK, which are implicated in insulin induced IRS-1 serine
phosphorylation and insulin resistance [28,29].
Another intriguing finding of the present study is the
observation that insulin stimulated IRS-1 serine phosphorylation
in the absence of T, while concomitantly inhibiting the
phosphorylation AKT beyond 30 minutes of insulin exposure
(Figures 2A and 3A). This additional finding indicates that insulin
can modulate its own signaling pathway. This finding is consistent
with a recent report that indicated that continually high insulin
levels impaired Akt phosphorylation and glucose transport in
human myoblasts [30].
Wechose an in vitro model to test our hypothesis. The invitro model
of the experimental design has limitations in that the model may not
always accurately represent to in vivo biology. However, in vitro studies
allow for the isolation of the effects of specific stimuli (in this case
testosterone) on aberrant protein signaling (in this case insulin-
stimulated IRS-1 Ser
636/639 phosphorylation) from complexities of in
vivo model. In addition, we chose to initially test our hypothesis in this
primary rat skeletal muscle myotubes, but future investigations are
warranted to determine whether T exposure has similar effects on
insulin-stimulated IRS-1 Ser
636/639 phosphorylation in primary
human skeletal muscle myotubes as well as in vivo in humans.
In conclusion, we report a specific link between a hyperinsu-
linemic, hyperandrogenic environment and an elevation of IRS-1
serine phosphorylation of IRS-1, which has been associated with
the development of insulin resistance. Specifically, our results
suggest that there is a synergistic interaction between T and insulin
in this effect beyond that of insulin alone. Additionally, we suggest
future studies utilizing primary skeletal muscle culture exposed to
T in the presence of a hyperinsulinemic environment may serve as
models for PCOS-related insulin resistance. These results agree
with the recent findings of elevated serine phosphorylation of IRS-
1 in cultured skeletal muscle of PCOS patients [11].
Materials and Methods
Skeletal Muscle Culture
The study protocol was approved by the Institutional Animal
Care and Use Committee of Mayo Clinic and Foundation.
Skeletal muscle was obtained from the soleus and EDL muscle of
an adult female Sprague-Dawley rat from which myoblasts were
isolated and cultured according to established protocols [31–33].
Specifically, muscle biopsy samples were collected in ice-cold
phosphate-buffered saline (PBS) supplemented with 1% PeSt (100
units/ml penicillin/100 mg/ml streptomycin). Fat and connective
tissue were dissected from the specimen in a sterile tissue culture
hood. The muscle was placed into a filter-sterilized collagenase
solution (0.2% type I collagenase (Sigma) in Dulbecco’s modified
Eagles medium (DMEM, Sigma) and incubated for 1.5 h at 37uC
in an oscillating water bath. Following digestion, the muscle cells
were transferred to a 100mm petri dish (Falcon) pre-rinsed with
DMEM containing horse serum (HS). A wide-bore pipet (Falcon)
was then used to gently separate muscle fibers while the mass of
muscle cells were then transferred to a fresh identically-prepared
petri dish and the separation process repeated. The supernatant
from each separation process was transferred to a non-coated
100mm petri dish and incubated for 1 h in a tissue culture
incubator at 37uC and 5% CO2 to promote adherence of non-
myogenic cells. The non-adherent cells from each non-coated dish
were then transferred to a 24-well tissue culture plate (Falcon)
precoated with 10% Matrigel and allowed to settle and attach for
3 min prior to the placement of 0.5 ml plating media (DMEM,
10% HS, 0.5% chick embryo extract (CEE), 1% PeSt) per well.
After 3 days, the media was changed to proliferation media
containing 20% fetal bovine serum (FBS), 10% HS, 0.5% CEE,
and 1% PeSt. The cells, when reached ,80% confluence, were
then subcultured according to standard techniques and transferred
to non-coated 75-cm
2 flasks (Falcon) for continued culture.
Myoblasts were differentiated into multi-nucleated myotubes
after 4 days in low-serum media containing DMEM, 2% FBS, and
1% PeSt. All protein experiments were performed using myotubes.
Immunohistochemical (IHC) Staining
Myoblasts, upon reaching 80% confluence, were trypsinized
and mounted on microscope slides for homogeneity estimation
Testosterone and Insulin
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1 (MHC-1) antibody (Sigma, M8421) Briefly, following trypsin-
ization the cells were suspended in 1% bovine serum albumin
(BSA)/PBS. The cell concentration was adjusted to 1610
5 cells/
ml by serial dilution. Two-hundred microliters of the cell
suspension was loaded into the cytofunnel to provide a final
concentration of 2610
4 cells per slide. The cells were spun at
600 rpm for 5 min to mount them on the slide. The slides were
dried for 2 hours prior to antibody staining. Following drying,
each slide was washed with PBS times for 1–2 min, followed by
acetone fixation for 1 min. The slides were dried for 10 min,
followed by an additional 1 min PBS wash. The slides were then
incubated for 10 min at room temperature (RT) in 100 ml of Dako
Cytomation Protein Block (DPBB) (DakoUSA x0909) with 1%
saponin (Sap) (Sigma S-7900 100X stock). Slides were exposed to
MHC-1 antibody (Ab) diluted 1:500 in DPBB-Sap for 1 hr at RT.
Negative control slides were incubated in DPBB-Sap for 1 hr at
RT. Slides were then washed 3 times in PBS for 5 min. Secondary
Ab (Molecular Probes Alexa Flour 488) was applied for 30 min.
Following PBS wash, slides were counterstained with a Hoescht
counterstain (Sigma B2883). Slides were then mounted with an
anti-fade agent (Molecular Probes P7481) and inspected using a
Zeiss LSM 510 confocal laser scanning microscope (Carl Zeiss,
Inc., Germany) set for excitation at 488 nm utilizing an argon/
krypton laser. Negative control slides were used to calibrate the
microscope prior to image analysis of the MHC-1 slides.
Western Blot Analysis
Sixteen hours prior to insulin exposure, differentiated myotube
cells were adapted to serum-free media containing 1% BSA
without testosterone (control, C) or with testosterone (T) at two
different concentrations, 20 ng/mL and 200 ng/mL. Then C and
T pre-exposed cells were treated with or without 100 nM insulin
(I) resulting in 6 experimental groups: C2I, C+I low T2I, low
T+I, high T2I and high T+I. The T concentrations were
empirically chosen. In brief, we used the upper physiologic limit
for T concentration for the low-dose T and multiplied it by a
factor of 10 base on our understanding that metabolic processes
occur at much faster rates in rats. We then performed preliminary
Western blots to determine if we could see a difference in protein
phosphorylation. Based on our preliminary results we designed the
experiment to compare the 2 concentrations. The 100 nM insulin
concentration was chosen, because it represents a standard in vitro
insulin concentration for stimulating glucose uptake [34]. Cells
and total proteins from the cells were collected using cell lysis
buffer supplemented with protease inhibitor cocktail (Cell
Signaling #9803, Roche complete mini #1836153) after 30 min-
utes, 1 hour, and 2 hours of insulin stimulation for the low-dose T
pre-exposed cells, and after 10, 20 and 30 min of insulin
stimulation for the high-dose T treated cells . For both the low-
dose and high-dose T exposed cells, the 30 min data is presented
based on preliminary experiments which suggested that at this
time point the phosphorylation status of IRS1 Ser
636/639 and S6k
plateaued, Akt reached its peak phosphorylation, and mTOR
phosphorylation remained unchanged. Total proteins were
separated by gel electrophoresis using the Invitrogen Mini Cell

system and NuPage 4–12% Tris-Bis gels. Proteins were then
transferred to PVDF membranes, and western blot analysis was
performed using antibodies against total and phosphorylated Akt
Ser
473 (Cell Signaling #9272, #9271), mTOR Ser
2448 (Cell
Signaling #2972, #2971), S6 kinase Thr
389 (Cell Signaling
#9202, #9205), and IRS-1Ser
636/639 (Cell Signaling #2382,
#2388). Signal intensities of phosphorylated and total proteins
were quantified and analyzed using Kodak image station 1000 and
the accompanying software packages. Phosphorylated signals were
normalized to total protein for each measurement. The net effect
of insulin on protein phosphorylation was determined using the
ratio of the insulin-treated phosphorylation signal to the non-
insulin treated phosphorylation signal for both control cells and T
exposed cells. The experiment was replicated six times for each
condition.
Statistics
Data are presented as the mean6SE. Statistical significances
were calculated using unpaired t-tests.
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